Log in

VYT Vytrus Biotech SA BME · Spain

Vytrus Biotech SA (VYT) news

Vytrus Biotech SA is a public biotech or pharmaceutical company listed on BME under the ticker VYT, recorded under Spain. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Vytrus Biotech SA news

We have not published a story on Vytrus Biotech SA yet. When there is news, it will appear here.

Questions about Vytrus Biotech SA

What is the ticker symbol of Vytrus Biotech SA?

Vytrus Biotech SA trades under the ticker VYT on BME.

Where is Vytrus Biotech SA listed?

Vytrus Biotech SA is listed on BME. Our directory also records these other listings: LSX:A3DHK4.

Which country or territory is Vytrus Biotech SA listed under?

Our directory records Vytrus Biotech SA under Spain.

What does Vytrus Biotech SA do?

Our directory classifies Vytrus Biotech SA as: Biotechnology. This is a directory classification, not a description of the pipeline.

What is the ISIN of Vytrus Biotech SA?

The ISIN recorded for Vytrus Biotech SA is ES0105618005.

Does aibio.space cover Vytrus Biotech SA?

aibio.space lists Vytrus Biotech SA among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Vytrus Biotech SA?

Companies in our directory listed in the same country and business area as Vytrus Biotech SA: Biotechnology Assets SA, LABORATORIO REIG JOFRE, Pharma Mar SA, Faes Farma, Grifols, Oryzon Genomics SA.

Investor discussion: Vytrus Biotech SA

Members talk about Vytrus Biotech SA (VYT). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open BME:VYT on TradingView.

Listing details

Vytrus Biotech SA is a public biotech or pharmaceutical company listed on BME under the ticker VYT, recorded under Spain. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Vytrus Biotech SA
Ticker
VYT
Listing
BME
Country or territory
Spain
Business scope
Biotechnology
ISIN
ES0105618005
Other listed symbols
LSX:A3DHK4
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.